Precigen, Inc. Enters Material Definitive Agreement
Ticker: PGEN · Form: 8-K · Filed: Aug 9, 2024 · CIK: 1356090
| Field | Detail |
|---|---|
| Company | Precigen, Inc. (PGEN) |
| Form Type | 8-K |
| Filed Date | Aug 9, 2024 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.85, $31.4 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-definitive-agreement
TL;DR
Precigen signed a big deal on Aug 7th.
AI Summary
On August 7, 2024, Precigen, Inc. entered into a material definitive agreement. The company, formerly known as Intrexon Corp, is incorporated in Virginia and headquartered in Germantown, Maryland.
Why It Matters
This filing indicates a significant new contract or partnership for Precigen, Inc., which could impact its future business operations and financial performance.
Risk Assessment
Risk Level: medium — Entering into material definitive agreements can carry inherent risks related to contract terms, performance obligations, and potential future disputes.
Key Numbers
- 001-36042 — Commission File Number (SEC filing identifier for Precigen, Inc.)
- 26-0084895 — I.R.S. Employer Identification No. (Tax identification number for Precigen, Inc.)
Key Players & Entities
- Precigen, Inc. (company) — Registrant
- Intrexon Corp (company) — Former name of Registrant
- August 7, 2024 (date) — Date of earliest event reported
- Virginia (jurisdiction) — State of incorporation
- 20374 Seneca Meadows Parkway, Germantown, Maryland 20876 (address) — Principal executive offices
FAQ
What is the nature of the material definitive agreement entered into by Precigen, Inc.?
The filing does not specify the nature of the material definitive agreement, only that one was entered into on August 7, 2024.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on August 7, 2024.
What was Precigen, Inc.'s former name?
Precigen, Inc.'s former name was Intrexon Corp.
Where are Precigen, Inc.'s principal executive offices located?
Precigen, Inc.'s principal executive offices are located at 20374 Seneca Meadows Parkway, Germantown, Maryland 20876.
In which state is Precigen, Inc. incorporated?
Precigen, Inc. is incorporated in Virginia.
Filing Stats: 766 words · 3 min read · ~3 pages · Grade level 11.4 · Accepted 2024-08-09 09:04:35
Key Financial Figures
- $0.85 — on Stock"), at a price to the public of $0.85 per share. Pursuant to the Underwriting
- $31.4 million — from the offering will be approximately $31.4 million after deducting the underwriting discou
Filing Documents
- tm2421213d1_8k.htm (8-K) — 29KB
- tm2421213d1_ex1-1.htm (EX-1.1) — 203KB
- tm2421213d1_ex5-1.htm (EX-5.1) — 10KB
- tm2421213d1_ex5-1img001.jpg (GRAPHIC) — 9KB
- 0001104659-24-087596.txt ( ) — 481KB
- pgen-20240807.xsd (EX-101.SCH) — 3KB
- pgen-20240807_lab.xml (EX-101.LAB) — 33KB
- pgen-20240807_pre.xml (EX-101.PRE) — 22KB
- tm2421213d1_8k_htm.xml (XML) — 3KB
01
Item 1.01 Entry into a Material Definitive Agreement. On August 7, 2024, Precigen, Inc. ("Precigen") entered into an underwriting agreement (the "Underwriting Agreement") with Stifel, Nicolaus & Company, Incorporated, as the representative of the several underwriters named therein (the "Underwriters"), in connection with the underwritten public offering (the "Offering") of 35,294,118 shares (the "Firm Shares") of Precigen common stock, no par value ("Common Stock"), at a price to the public of $0.85 per share. Pursuant to the Underwriting Agreement, Precigen granted to the Underwriters the option to purchase up to an additional 5,294,117 shares of Common Stock (together with the Firm Shares, the "Shares") for a period of 30 days from the date of the Underwriting Agreement. Net proceeds to Precigen from the offering will be approximately $31.4 million after deducting the underwriting discount and other estimated offering expenses payable by Precigen, such proceeds including the sale of 4,584,821 shares of Common Stock exercised pursuant to the Underwriters' option to purchase additional shares. The Offering was made pursuant to Precigen's shelf registration dated August 7, 2024. The Underwriting Agreement includes certain customary representations, warranties, and covenants by Precigen, and it provides that Precigen will indemnify the Underwriters against certain liabilities, including liabilities under the Securities Act of 1933, as amended, or contribute to payments the Underwriters may be required to make because of any of those liabilities. The representations, warranties, and covenants contained in the Underwriting Agreement were made only for purposes of such agreement and as of specific dates, were solely for the benefit of the parties to such agreement, and may be subject to limitations agreed upon by the contracting parties
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 1.1 Underwriting Agreement, dated August 7, 2024, between Precigen, Inc. and Stifel, Nicolaus & Company, Incorporated. 5.1 Opinion of Hogan Lovells US LLP. 23.1 Consent of Hogan Lovells US LLP (contained in Exhibit 5.1). 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Precigen, Inc. By: /s/ Donald P. Lehr Donald P. Lehr Chief Legal Officer Dated: August 9, 2024